We pursue selected, shared risk /reward partnerships to develop internal IP programmes that address major unmet medical needs.

We combine our internal expertise in venom biology and drug discovery with that of partners who have developed unique phenotypic assays or other biologic tools for identifying drug leads in our venoms' components.

 Targeted venom fractions

We expect that some of these programmes will generate IP-protected molecules that increase the value of the company. Please contact us to discuss a partnership with Venomtech.

Targeted Venom Arrays

Ion channel venoms

Ion Channels

New and exciting approaches to ion-channel pathways

GPCR's venom


Our peptides are unlocking GPCR targets in many applications

Kinases venom  


Our peptides are providing solutions for research into Kinases

Epigenetics venom


Effective solutions for hard-to-hit epigenetic targets

Antimicrobial Resistance venoms

Antimicrobial Resistance

Our peptides are natural solutions for modulating resistant entities

S100 Proteins venom

S100 Proteins

We are hitting S100 targets

Resources: Supporting material to aid your research

Papers and posters venom

Papers & Posters

Helpful Publications from our Team, our Partners and key Industry sources

News and events venom

News & Events

Up-to-date events and news items about the species, the science and our Team

People and partners venom

People & Partners

Find out more about our core and extended team, get in touch, collaborate!